Status:
UNKNOWN
The Effect of PEMF for Patients With Quadriceps Muscle Weakness After ACLR
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Anterior Cruciate Ligament Injuries
Quadriceps Muscle Atrophy
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
In Hong Kong, over 3000 Anterior Cruciate Ligament Reconstructions (ACLR) are performed each year in order to restore knee function after an ACL injury. The ultimate goal of ACLR is to fulfil the retu...
Eligibility Criteria
Inclusion
- Aged 18-50 with a unilateral ACL injury
- Sporting injury with a Tegner score of 7+
- LSI for quadriceps strength \<70% of the contralateral leg at 4 months post-up
- Both knees without a history of injury/prior surgery
Exclusion
- Ages smaller than 18 years old or greater than 50 years old
- Any concomitant bone fracture, major meniscus injury or full-thickness chondral injuries requiring altered rehabilitation program post-op
- Preoperative radiographic signs of arthritis
- Metal implants that would cause interference on MRI
- Non-HS graft for ACLR
- Patient non-compliance to the rehabilitation program
- Pregnancy or possibility of pregnancy
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05184023
Start Date
September 1 2021
End Date
September 1 2025
Last Update
December 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong
Hong Kong, Hong Kong